Search

Your search keyword '"Interleukin 37"' showing total 45 results

Search Constraints

Start Over You searched for: Descriptor "Interleukin 37" Remove constraint Descriptor: "Interleukin 37"
45 results on '"Interleukin 37"'

Search Results

1. Genetic variations of interleukin 32(rs28372698) and interleukin 37 (rs3811047), and their serum levels in systemic lupus erythematosus patients.

2. Interleukin 37 inhibits the migration and invasion of Glioma cells.

3. Neutrophil-derived nanovesicles deliver IL-37 to mitigate renal ischemia-reperfusion injury via endothelial cell targeting.

4. Interleukin-37 contributes to endometrial regenerative cell–mediated immunotherapeutic effect on chronic allograft vasculopathy.

5. Potential Role of IL-37 in Atopic Dermatitis.

6. Rationale for IL-37 as a novel therapeutic agent in inflammation.

7. LEVELS OF IL-37 AND IgA AMONG PNEUMONIA PATIENTS.

8. Plasma Level of Interleukin 37 in Children with Primary Immune Thrombocytopenia.

9. IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation

10. Interleukin 37 Suppresses M1 Macrophage Polarization Through Inhibition of the Notch1 and Nuclear Factor Kappa B Pathways

11. Expression level of serum Interleukin-37 in Rheumatoid Arthritis patients and its correlation with Disease Activity Score

12. IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation.

13. Extracellular and nuclear roles of IL-37 after spinal cord injury.

14. PCR Genetic Expression of Interleukin 37 in the Eutopic and Ectopic Endometrium of Women with Endometriosis.

15. Association of the IL-37 Polymorphisms with Transaminases and Alkaline Phosphatase Levels in Premature Coronary Artery Disease Patients and Healthy Controls. Results of the Genetics of Atherosclerotic (GEA) Mexican Study

16. Parsing the IL-37-Mediated Suppression of Inflammasome Function.

17. IL-37 Gene and Cholesterol Metabolism: Association of Polymorphisms with the Presence of Hypercholesterolemia and Cardiovascular Risk Factors. The GEA Mexican Study

18. IL-37 suppresses migration and invasion of gallbladder cancer cells through inhibition of HIF-1α induced epithelial-mesenchymal transition.

19. Ethanol‐mediated suppression of IL‐37 licenses alcoholic liver disease.

20. Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance.

21. Effect of exogenous IL-37 on immune cells from a patient carrying a potential IL37 loss-of-function variant: A case study.

22. Increased Expression of Interleukin 37 in the Eutopic and Ectopic Endometrium of Patients With Ovarian Endometriosis.

23. IL-37 Gene and Cholesterol Metabolism: Association of Polymorphisms with the Presence of Hypercholesterolemia and Cardiovascular Risk Factors. The GEA Mexican Study

24. IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation

25. Interleukin 37; a possible marker of arterial stiffness in Behçet's disease.

26. In silico and in vivo analysis of IL37 in multiple sclerosis reveals its probable homeostatic role on the clinical activity, disability, and treatment with fingolimod

27. Parsing the IL-37-Mediated Suppression of Inflammasome Function

28. Association between interleukin 37 (rs3811047) polymorphism and multiple autoimmune diseases in a Chinese population: A PRISMA-compliant meta-analysis

30. Association of the IL-37 Polymorphisms with Transaminases and Alkaline Phosphatase Levels in Premature Coronary Artery Disease Patients and Healthy Controls. Results of the Genetics of Atherosclerotic (GEA) Mexican Study.

31. Interleukin 37 Expression Inhibits STAT3 to Suppress the Proliferation and Invasion of Human Cervical Cancer Cells

32. IL-37 Gene and Cholesterol Metabolism: Association of Polymorphisms with the Presence of Hypercholesterolemia and Cardiovascular Risk Factors. The GEA Mexican Study.

33. Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance

34. Serum levels of Interlökin-37 in patients with systemic sclerosis and its' association with clinical parameters

35. Periodontitisli bireylerde dişeti oluk sıvısındaki IL-1 Beta, IL-1Ra, IL-6, IL-17, IL-23, IL-33, IL-37 düzeylerinin karşılaştırılması

36. In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod.

37. Therapeutic role of IL-­‐37 after injury to the nervous system

38. Generalize agresif periodontitis hastalarında, konvansiyonel mekanik periodontal tedaviye ek olarak kullanılan diyot ve Er,Cr:YSGG lazer uygulamalarının klinik ve biyokimyasal olarak değerlendirilmesi

39. Behçet hastalığı'nda interlökin 37 düzeyi ve interlökin 37 gen polimorfizminin prediktif ve prognostik önemi

40. Investigation of the immune response and gene expression in endometriosis

41. Influenza A virus inhibits influenza virus replication by inducing IL-37.

42. Expression and Purification of Tag-removed Human IL37 by Digestion on Beads in Escherichia coli.

44. Interleukin 37 Expression Inhibits STAT3 to Suppress the Proliferation and Invasion of Human Cervical Cancer Cells.

45. Downregulated interleukin 37 expression associated with aggravation of intervertebral disc degeneration.

Catalog

Books, media, physical & digital resources